Telemedicine and Diabetes During the COVID-19 Era

Overview

Journal Arch Med Sci Atheroscler Dis

Date 2022 Sep 26

PMID 36158062

Authors

Athanasia Papazafiropoulou

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic affected everyone's life and especially those with chronic conditions, such as diabetes. Therefore, the need for medical care in such populations resulted in identification of new models of health care avoiding physical consultation and reducing the risk of COVID-19 transmission, giving emphasis to telemedicine. There is an increasing amount of studies showing the beneficial impact of the use of telemedicine in patients with type 1 diabetes, while for patients with type 2 diabetes the existing data are limited and conflicting. Therefore, the aim of the present review is to summarize the existing literature data on the impact of telemedicine on the follow-up of patients with diabetes during the pandemic as well as its place in the management of patients with diabetes in the future.

Citing Articles

How Does the Psychological Impact of COVID-19 Affect the Management Strategies of Individuals with Type 1 and Type 2 Diabetes? A Mixed-Method Study.

Madkhali N Healthcare (Basel). 2024; 12(17).

PMID: 39273735 PMC: 11395634. DOI: 10.3390/healthcare12171710.

Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review.

Mirasghari F, Ayatollahi H, Velayati F, Abasi A J Clin Transl Endocrinol. 2024; 37:100361.

PMID: 39114582 PMC: 11304064. DOI: 10.1016/j.jcte.2024.100361.

Comparison of Glycemic Control Between In-Person and Virtual Diabetes Consults in Hospitalized Patients With Diabetes.

Luzuriaga M, Lieberman M, Ma R, Casula S, Lagari-Libhaber V, Messinger S J Diabetes Sci Technol. 2023; 19(2):400-406.

PMID: 37727950 PMC: 11874324. DOI: 10.1177/19322968231199470.

References

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Lee J, Carlson E, Albanese-ONeill A, Demeterco-Berggren C, Corathers S, Vendrame F . Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic. Diabetes Technol Ther. 2021; 23(9):642-651. PMC: 8501471. DOI: 10.1089/dia.2021.0080. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

El Moazen G, Pfeifer B, Loid A, Kastner P, Ciardi C . The Effectiveness of Telemedical Monitoring Program DiabCare Tirol for Patients with Gestational Diabetes Mellitus. Stud Health Technol Inform. 2021; 285:205-210. DOI: 10.3233/SHTI210599. View

Bonora B, Boscari F, Avogaro A, Bruttomesso D, Fadini G . Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther. 2020; 11(6):1369-1379. PMC: 7213551. DOI: 10.1007/s13300-020-00829-7. View

Evin F, Er E, Ata A, Jalilova A, Demir G, Atik Altinok Y . The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases. J Clin Res Pediatr Endocrinol. 2020; 13(4):468-472. PMC: 8638622. DOI: 10.4274/jcrpe.galenos.2020.2020.0160. View

Luzi L, Carruba M, Crialesi R, Da Empoli S, Dagani R, Lovati E . Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture. Acta Diabetol. 2021; 58(7):919-927. PMC: 7977495. DOI: 10.1007/s00592-021-01700-2. View

Sangave N, Aungst T, Patel D . Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology. Diabetes Spectr. 2019; 32(4):378-384. PMC: 6858073. DOI: 10.2337/ds18-0069. View

Mishra M, Bano T, Mishra S, Wasir J, Kohli C, Kalra S . Effectiveness of diabetes education including insulin injection technique and dose adjustment through telemedicine in hospitalized patients with COVID-19. Diabetes Metab Syndr. 2021; 15(4):102174. PMC: 8196469. DOI: 10.1016/j.dsx.2021.06.011. View

10.

Scott S, Fontana F, Zuger T, Laimer M, Stettler C . Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey. Endocrinol Diabetes Metab. 2021; 4(1):e00180. PMC: 7831200. DOI: 10.1002/edm2.180. View

11.

Peters A, Garg S . The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Diabetes Technol Ther. 2020; 22(6):449-453. DOI: 10.1089/dia.2020.0187. View

12.

Zhai Y, Zhu W, Cai Y, Sun D, Zhao J . Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2014; 93(28):e312. PMC: 4603080. DOI: 10.1097/MD.0000000000000312. View

13.

Garg S, Rodbard D, Hirsch I, Forlenza G . Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities. Diabetes Technol Ther. 2020; 22(6):431-439. DOI: 10.1089/dia.2020.0161. View

14.

Schiller T, Zornitzki T, Ostrovsky V, Sapojnik D, Cohen L, Kunyavski T . Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format. Int J Environ Res Public Health. 2021; 18(21). PMC: 8583150. DOI: 10.3390/ijerph182111309. View

15.

Scott S, Fontana F, Helleputte S, Pickles J, Laimer M, Zueger T . Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-Up. Diabetes Technol Ther. 2021; 24(4):276-280. DOI: 10.1089/dia.2021.0426. View

16.

Ghosh A, Gupta R, Misra A . Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr. 2020; 14(4):273-276. PMC: 7129346. DOI: 10.1016/j.dsx.2020.04.001. View

17.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

18.

Norgaard K . Telemedicine Consultations and Diabetes Technology During COVID-19. J Diabetes Sci Technol. 2020; 14(4):767-768. PMC: 7673191. DOI: 10.1177/1932296820929378. View

19.

Dixon R, Zisser H, Layne J, Barleen N, Miller D, Moloney D . A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. J Diabetes Sci Technol. 2019; 14(5):908-911. PMC: 7477772. DOI: 10.1177/1932296819888662. View

20.

Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali G, Rusch E . Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Telemed J E Health. 2018; 25(7):569-583. DOI: 10.1089/tmj.2018.0128. View